Home
Search

Letters, Testimony & Comments

BIO submits letters, testimony, and comments to government and regulatory bodies throughout the United States and around the world.

Featured Letters, Testimony, & Comments
Agriculture Biotech Alliance Letter to House Ag…
On behalf of our nation’s food and agricultural stakeholder community, we write to extend our appreciation for holding today’s hearing on “Agricultural Biotechnology: 21st Century Advancements and Applications.” Biotechnology is an increasingly…
Learn more
BIO Submits Statement to House Ag Joint Hearing…
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture joint hybrid subcommittee hearing, Agricultural Biotechnology: 21st Century…
Learn more
BIO Joins Letter Supporting Elaine Trevino as…
BIO is pleased to join the undersigned food and agriculture organizations and companies in supporting the nomination of Elaine Trevino to serve as Chief Agricultural Negotiator at the Office of the U.S. Trade Representative.
Learn more
All Letters, Testimony & Comments
  • Show All
Search
Agriculture Biotech Alliance Letter to House Ag Committee on Importance of Biotechnology
October 26, 2021
On behalf of our nation’s food and agricultural stakeholder community, we write to extend our appreciation for holding today’s hearing on “Agricultural Biotechnology: 21st Century Advancements and Applications.” Biotechnology is an increasingly…
BIO Submits Statement to House Ag Joint Hearing on Agriculture Biotechnology
October 26, 2021
The Biotechnology Innovation Organization (BIO) is pleased to submit a statement for the record to the United States House of Representatives Committee on Agriculture joint hybrid subcommittee hearing, Agricultural Biotechnology: 21st Century…
BIO Joins Letter Supporting Elaine Trevino as Chief Ag Negotiator at USTR
October 15, 2021
BIO is pleased to join the undersigned food and agriculture organizations and companies in supporting the nomination of Elaine Trevino to serve as Chief Agricultural Negotiator at the Office of the U.S. Trade Representative.
Congressional Letter to Administration on Importance of Animal Biotechnology
October 8, 2021
As you know, several challenges facing the agriculture industry and our communities have emerged or intensified in recent years. Zoonotic disease, climate change, and a growing global population require us to consider new solutions to protect our…
BIO Supporting Oxitec’s Experimental Use Permit (EUP) for Biotech Mosquito
September 30, 2021
The Biotechnology Innovation Organization (BIO) submits these comments in response to the U.S. Environmental Protection Agency’s (EPA) request for public input on the receipt of an application, 93167-EUP-2, from Oxitec Ltd requesting to amend and…
BIO Signs Letter to House Leadership on Need to Protect Qualified Small Business Stock
September 30, 2021
The undersigned organizations write to encourage policymakers to remove provisions in the Build Back Better Act that would curtail the effectiveness of Qualified Small Business Stock (QSBS) in incentivizing investment in innovative small businesses…
BIO Testimony to House Agriculture Hearing on Carbon Markets
September 23, 2021
To meet the challenge of climate change, it is crucial to lead with science and U.S. innovation. We must incentivize the adoption of innovative, sustainable technologies and practices; and streamline and expedite regulatory pathways for breakthrough…
Supporting U.S. Food & Agriculture Innovation & Climate Objectives
September 23, 2021
Safe, secure, affordable & accessible food supply Hundreds of millions of Americans and people around the world rely on safe and nutritious U.S. agricultural products and foods. Americans have access to one of the safest, most diverse, most…
Open Letter to the President of the United States: The Need for U.S. Leadership in Global Vaccinations
August 10, 2021
We want to commend you and your Administration for the global distribution of millions of doses of the COVID-19 vaccines. Our friends in recipient countries are truly grateful. Nonetheless, in order to gain control of the pandemic, a much more…
BIO Comments on Core PROs in Cancer Clinical Trials
August 9, 2021
On Thursday, June 10th, 2021, the U.S. Food and Drug Administration (FDA) published a draft guidance, Core Patient-Reported Clinical Outcomes in Cancer Clinical Trials, providing recommendations to sponsors on the collection of a core set of patient…